This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Cisatracurium besylate

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

2

Spl Product Data Elements

cisatracurium besylate cisatracurium besylate CISATRACURIUM BESYLATE CISATRACURIUM BENZENESULFONIC ACID BENZYL ALCOHOL WATER

Application Number

ANDA213527

Brand Name

Cisatracurium besylate

Generic Name

cisatracurium besylate

Product Ndc

72785-0011

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Container Label (20 mg/10 mL) NDC 72758-0011-1 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 mL Multiple-Dose Vial Rx only Carton Label (20 mg/10 mL) NDC 72758-0011-1 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 mL Multiple-Dose Vial Rx only Carton Label (20 mg/10 mL) NDC 72758-0011-6 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 x 10 mL Multiple-Dose Vial Rx only vial label carton for 1 vial carton of 10 vials

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.